REPROCELL

Better translating discoveries into therapies. Follow for updates about products, services, and industry news.

[REPROCELL @_REPROCELL]

Want actionable insights from your data? Pharmacology-AI delivers quick and easily interpretable analysis outputs. Identify responsive patient populations, enable smarter clinical trial design, and improve your chances of clinical success.

[REPROCELL @_REPROCELL]

A big thank you to everyone who connected with the REPROCELL team at Advanced Therapies Week 2025! If we missed you, schedule a meeting https://t.co/ADVcnFyOJ1 to explore our clinical services and GMP-grade iPSCs. We look forward to future collaborations!

[REPROCELL @_REPROCELL]

What sets REPROCELL's Seed and Pilot clones apart?

✅ Seed Clones: GMP-compliant, ready for GMP MCBs and clinical use.
🔬 Pilot Clones: Cost-effective, research-use iPSCs derived from Seed Clones, ideal for process optimization.
🌐https://t.co/6jX6OEmi15

[REPROCELL @_REPROCELL]

It’s been fantastic meeting so many people at Advanced Therapies Week 2025 in Dallas! Tomorrow’s the final day. Request a virtual meeting at https://t.co/Vs8Xayejlb or email Joey directly at [email protected] to explore our clinical services and GMP-grade iPSCs.

[REPROCELL @_REPROCELL]

Exciting News! Advanced Therapies Week 2025 is live in Dallas! Meet @_REPROCELL 's Stem Cell expert Joseph Rogers to explore our clinical services and GMP-grade iPSCs. Virtual meetings available! https://t.co/Vs8Xayejlb

[REPROCELL @_REPROCELL]

The CEO & Co-Founder of Gameto, Dr. Dina Radenkovic, shares insights on their groundbreaking journey to revolutionize fertility care. Don’t miss this behind-the-scenes look at Fertilo- the future of women’s health.

Read the blog now: https://t.co/oppylKzZHq

[REPROCELL @_REPROCELL]

At REPROCELL, we offer customized iPSC solutions for your cell therapy program or research project by leveraging our own StemRNA™ Reprogramming Technology. Choose your own donor profiles or access our bank of clinical-grade iPSC clones.

Contact us here: https://t.co/GmXL4IPwIl

[REPROCELL @_REPROCELL]

Prof. Stefan Przyborski will be speaking at a research seminar covering the commercialisation and technologies for in vitro models. Register here if you’re interested! https://t.co/QErY1bmz5G

[REPROCELL @_REPROCELL]

REPROCELL is excited to be #hiring for a new Scientific Sales Representative for our Glasgow office. If this interests you, please apply at the link below. We can’t wait for you to join our team! https://t.co/069mIaS68L

[REPROCELL @_REPROCELL]

FDA Approves First MSC Therapy! RYONCIL® offers hope for children with SR-aGvHD, achieving a 70% response rate in 28 days. At REPROCELL, we provide GMP iMSCs & MSCs to drive innovation.

Learn more: https://t.co/s4qLWZlnuD | https://t.co/H3gdteagVW

#CellTherapy #FDA #Innovation

[REPROCELL @_REPROCELL]

As previously shared, Gameto achieved a groundbreaking milestone with the birth of the first baby using Fertilo, their innovative oocyte maturation technology. We’re proud that our StemRNA iPSCs played a key role!

Learn more: https://t.co/hULgleudpd

[REPROCELL @_REPROCELL]

A new fascinating insight in Science into the pulsatile motion of blood vessels might help the brain to wash itself during sleep. We regularly see this in our studies with human living arteries. https://t.co/XWfND5GQOO

Read the Science article here: https://t.co/lxwgpzILMw

[REPROCELL @_REPROCELL]

We’re partnering with Qkine Ltd. to bring precision bioactive proteins to scientists worldwide. Together, we’re advancing stem cell research, differentiation, & organoid workflows!

Read the press release here: https://t.co/LU9gs1qBVG

#Innovation #RegenerativeMedicine

[REPROCELL @_REPROCELL]

Will you be at ATW 2025 in Dallas? Join us Jan 20-23 at the Kay Bailey Hutchison Center! Connect with Stem Cell Expert Joseph Rogers and discover @_REPROCELL services! 💥 If you have not yet registered, contact Joey at [email protected] to receive a discount code.

[REPROCELL @_REPROCELL]

Human tissue testing isn’t just about validating drugs, it’s about uncovering issues early, saving time, resources, and lives. Real human insights = smarter, safer decisions. Let’s bridge the gap between lab models and patient outcomes.

[REPROCELL @_REPROCELL]

REPROCELL’s clinical-grade iPSCs reprogrammed with StemRNA™ 5.0 Technology, offer:

• Donor-matched exclusive Seed Clones
• Ready-to-use Seed Clones for evaluation
• Matching economic Pilot Clones for research

🌐https://t.co/Ifmh9UImbF
📩Contact us: https://t.co/1bvakz4viu

[REPROCELL @_REPROCELL]

No matter your New Year’s resolution, REPROCELL is here to help. Dive into our newest publications from last year to read and explore more. Take a look at our papers here: https://t.co/4uveW36sMF

[REPROCELL @_REPROCELL]

Discover our clinical-grade iPSC clones validated to differentiate into neural lineage, hematopoietic stem cells, cardiomyocytes, NK cells, MSCs & more!
🌐 Explore our capabilities: https://t.co/yrjDAXYXpT
📩 Contact us: https://t.co/8HqrEkkdYb

#CellTherapy #Innovation

[REPROCELL @_REPROCELL]

What factors matter most when choosing a clinical iPSC provider—costs, reprogramming technology, licensing, or starting material? Our article published on BioInformant breaks it down to help you avoid complications.
📖 Read here: https://t.co/MvzcQUq0jG

#iPSCs #cGMP

[REPROCELL @_REPROCELL]

Looking for GMP-compliant iPSCs for clinical research? REPROCELL delivers high-quality, scalable iPSCs with rigorous QC & global donor access. Power your breakthroughs with our expertise!

💡Contact us today: https://t.co/JmTi4o1xn0

#iPSC #StemCell